Pharmacologic treatments for covid-19 patients

Inhaled nebulised interferon beta-1a vs Placebo

This comparison will not be updated. Last search date 14 Dec, 2022


Hospitalized patients

Forest plots
(last update: 2021-06-18)

To access all information :

You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.

Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=163

Back to your research

Trial Funding Comparisons Design Participants Sample size Overall risk
of bias
Highest assessment
Full description
Treatment 1 Treatment 2
NCT04385095 ; EudraCT 2020-001023-14
Monk PD, Lancet Respir Med, 2020
Full text
Commentary
Commentary
Private

Nebulised interferon beta-1a

Placebo

RCT Patients with confirmed COVID-19 (mild-severe) admitted to nine centers in the UK N=101
Some concerns
Details

Full description